On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Established in 2014 as one of the nation’s first programs focused on meeting the complex health needs of underserved communities and marginalized populations, the Allegheny Health Network’s Center for Inclusion Health has grown in the Western Pennslyvania region to provide coordinated and compassionate care delivery using evidence-based interventions.
The Center for Inclusion Health provides a myriad of health services that address disparities in access for mental health, homeless care, transgender care, and addiction medicine, as well as social determinants of health such as food insecurity and housing challenges.
On this episode of Managed Care Cast, we speak with the Division Chief of the Center for Inclusion Health, Elizabeth Cuevas, MD, a board-certified internal medicine physician, who speaks on the major health issues affecting patient outcomes in marginalized communities, the importance of community-level partnerships to identify and address these challenges, and opportunities for growth in managing these populations.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Challenges in developing next-generation cancer therapies persist; research indicates widespread utilization and hurdles in affordability and access to glucagon-like peptide-1 (GLP-1) medications; legislation seeks to legalize therapeutic use of psychedelics in California.
Read More